In ovarian cancer, GPER functions as a fatty acid receptor mechanism involving increased expression of apoptotic proteins such as B-cell lymphoma 2-like protein 11 (Bim) and Bax, and promotion of protein kinase A (PKA) activity and cyclic adenosine monophosphate (cAMP) levels. This evidence concerns the gene BAX and ovarian carcinoma.